A Study to Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Adults
Clinical trial NCT02485301 · COMPLETED
Trial details
- NCT number
- NCT02485301
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-15
- Primary completion
- 2016-12-23
- Enrollment
- 3024
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.